- Home
- / Yongtai Biopharmaceutical
Yongtai Biopharmaceutical
Stock Price
$1.8
2024-10-29
Market Capitalization
$1 B
2024-10-29
Yongtai Biopharmaceutical Summary
Company Summary
- Overview
- Yongtai Biopharmaceutical is a company that develops and commercializes cell immunotherapy products. It offers cell series and drugs for the treatment of cancer disease.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- Hong Kong, HK | view all locations
- Website
- http://www.eaal.net
- Cybersecurity rating
Table of Contents
Key People
Wang Yu, Executive Director and Chief Executive Officer, Co-Chief Technology Officer
Zheng Xuanzhe, Chief Strategy Officer
Zhang Jian, Senior Vice President
LocationsView all
2 locations detected
Hong Kong, Hong Kong Island HQ
Hong Kong
31/F, Times Square Tower 2, 1 Matheson Street
Beijing, Beijing
China
8th Floor, Building 1, No. 1 Kangding Street, Beijing Economic and Technological Development Zone
Yongtai Biopharmaceutical Financials
Summary Financials
- Gross profit (FY, 2025)
- ¥20.0M
- Net income (FY, 2025)
- (¥230.9M)
- Cash (FY, 2025)
- ¥54.5M
- EBIT (FY, 2025)
- (¥155.7M)
- Enterprise value
- $1.4B